Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) EBT Margin (2016 - 2025)

Historic EBT Margin for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 312.94%.

  • Jaguar Health's EBT Margin rose 94800.0% to 312.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 348.22%, marking a year-over-year increase of 174800.0%. This contributed to the annual value of 335.79% for FY2024, which is 934800.0% up from last year.
  • Latest data reveals that Jaguar Health reported EBT Margin of 312.94% as of Q3 2025, which was up 94800.0% from 354.48% recorded in Q2 2025.
  • Jaguar Health's EBT Margin's 5-year high stood at 252.52% during Q4 2022, with a 5-year trough of 3657.4% in Q2 2021.
  • Its 5-year average for EBT Margin is 694.79%, with a median of 400.29% in 2022.
  • In the last 5 years, Jaguar Health's EBT Margin plummeted by -33657100bps in 2021 and then skyrocketed by 33359400bps in 2022.
  • Jaguar Health's EBT Margin (Quarter) stood at 688.37% in 2021, then skyrocketed by 63bps to 252.52% in 2022, then crashed by -60bps to 404.74% in 2023, then grew by 28bps to 291.65% in 2024, then decreased by -7bps to 312.94% in 2025.
  • Its EBT Margin stands at 312.94% for Q3 2025, versus 354.48% for Q2 2025 and 478.59% for Q1 2025.